期刊文献+

CD133^+结直肠肿瘤干细胞中ABC转运蛋白的表达 被引量:2

Expression of ABC transporters in CD133^+ colorectal cancer stem cells
下载PDF
导出
摘要 目的探讨CD133+结直肠肿瘤干细胞表面ABC转运蛋白的表达。方法运用流式细胞仪(FACS)分析结直肠肿瘤细胞中CD133的表达,通过实时荧光定量PCR分析9种常见ABC转运蛋白在结直肠肿瘤细胞及正常组织细胞中的表达情况,并筛选出在肿瘤组织中高表达的ABC转运蛋白做免疫荧光分析,观察CD133+细胞中ABC转运蛋白的表达。结果有(2.59±1.26)%的结直肠肿瘤细胞表达CD133表面标记,在9种ABC转运蛋白中,MRP1在结直肠肿瘤细胞中表达显著高于正常组织细胞,共聚焦显微分析后证明CD133+细胞为主要MRP1表达细胞。结论 MRP1为结直肠肿瘤中主要表达的ABC转运蛋白,并且这一转运蛋白集中表达在CD133+肿瘤细胞中。 [Objective] To investigate the expression and distribution of ABC transporters in CD133 positive human eoloreetal cancer stem cells. [Methods] The expression of CD133 in coloreetal cancer ceils was analyzed by flow cytometry (FACS). Expression of ABC transporters was analyzed for tumor and normal control tissues by real-time fluorescence quantitative PCR. Those ABC transporters that were highly expressed in tumor tissues were selected and further analyzed for expression in CD133^+ and CD133- tumor cells. [Results] In fresh colorectal cancer Tissues, 2.59% CD133 positive ceils were detected. Among nine ABC transporters analyzed, MRP1 is expressed signifieandy higher in tumor tissues than in normal controls. Co-focus microscopy analysis showed that the majority of MRP1 positive cells were CD133 positive. [Conclusion] ABC transporter MRP1 is highly expressed in human eolorectal cancers comparing with normal tissues, and is primarily expressed by CD133 positive cancer cells.
出处 《中国现代医学杂志》 CAS CSCD 北大核心 2011年第17期1962-1966,共5页 China Journal of Modern Medicine
基金 宁夏科技厅重大科技攻关项目基金(No:232号)
关键词 结直肠肿瘤 肿瘤干细胞 CD133 ABC转运蛋白 eolorectal cancer cancer stem cells CD133 ABC transporter
  • 相关文献

参考文献14

  • 1YING JY, KANWAR SS, PATEL BB, et al. Elimination of colon cancer stem-like cells by combination of curcumin and folfox[J]. Translational Oncology, 2009, 2(4): 321-328.
  • 2PRESNELL SC, PETERSEN B, and Heidaran M. Stem cells in adult tissues[J]. Semin Cell Dev Biol, 2002, 13(5): 369-376.
  • 3REYA T, MORRISON SJ, CLARKE MF, et al. Stem ceils, ean- cer, and cancer stem ceils[J]. Nature, 2001, 414, 105-111.
  • 4FRANCIPANE MG, ALEA MP, LOMBARDO Y, et al. Crucial Role of Interleukin-4 in the survival of colon cancer stem cells [J]. Cancer Res, 2008, 68(11): 4022-4025.
  • 5GOTTESMAN MM, FOJO T, BATES SE. Muhidrug resistance in cancer: role of ATP-dependent transporters [J]. Nat Rev Cancer, 2002, 2(1): 48-58.
  • 6BERTOLINI G, ROZ L, PEREGO P, et al. Highly tumorigenic lung cancer CD133+ ceils display stem-like features and are spared by eisplatin treatment [J]. Proc Natl Acad Sci, 2009, 106 (38): 16281-16286.
  • 7LIU GT, YUAN XP, ZENG ZH, et al. Analysis of gene expres- sion and chemoresistance of CD133+ cancer stem cells in glioblastoma[J]. Mol Cancer, 2006, 5: 67.
  • 8DYLLA S J, BEVIGLIA L, PARK IK, et al. Colorectal cancerstem cells enriched in xenogeneic tumors followingchemotherapy[J]. PLoSONE, 2008, 3(6): e2428.
  • 9SHMELKOV SV, STCLAIR R, LYDEN D, et al. AC133/CD133/Prominin-l[J]. Int J Biochem Cell Biol, 2005, 37(4): 715-719.
  • 10O'BRIEN CA, POLLETr A, GALLINGER S, et al. A human colon cancer cell capable of initiating tumour growth in immun- odeficient mice[J]. Nature, 2007, 445(7123): 106-110.

同被引文献6

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部